Universal Health Services (NYSE:UHS) Updates FY 2026 Earnings Guidance

Universal Health Services (NYSE:UHS) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided earnings per share guidance of 22.280-23.650 for the period, compared to the consensus earnings per share estimate of 23.440. The company issued revenue guidance of $18.5 billion-$18.8 billion, compared to the consensus revenue estimate of $18.5 billion.

Universal Health Services Stock Up 4.6%

Universal Health Services stock opened at $166.67 on Wednesday. The firm has a market capitalization of $10.09 billion, a price-to-earnings ratio of 6.79, a price-to-earnings-growth ratio of 0.85 and a beta of 1.07. Universal Health Services has a fifty-two week low of $140.08 and a fifty-two week high of $246.32. The stock’s fifty day moving average is $150.40 and its two-hundred day moving average is $178.81. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.01 and a current ratio of 1.08.

Universal Health Services (NYSE:UHS) last announced its earnings results on Monday, July 27th. The health services provider reported $5.98 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.94 by $0.04. The company had revenue of $4.64 billion during the quarter, compared to analysts’ expectations of $4.58 billion. Universal Health Services had a net margin of 8.42% and a return on equity of 19.53%. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $5.35 earnings per share. Universal Health Services has set its FY 2026 guidance at 22.280-23.650 EPS. Analysts predict that Universal Health Services will post 23.44 EPS for the current fiscal year.

Universal Health Services Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend is Tuesday, September 1st. Universal Health Services’s payout ratio is currently 3.33%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on UHS shares. Weiss Ratings downgraded Universal Health Services from a “hold (c)” rating to a “hold (c-)” rating in a report on Tuesday, July 14th. Royal Bank Of Canada decreased their price objective on shares of Universal Health Services from $216.00 to $190.00 and set a “sector perform” rating for the company in a research note on Wednesday, April 29th. Robert W. Baird reduced their price target on Universal Health Services from $204.00 to $166.00 and set a “neutral” rating on the stock in a research report on Wednesday. Mizuho lowered their target price on Universal Health Services from $267.00 to $230.00 and set an “outperform” rating for the company in a research note on Wednesday, April 29th. Finally, UBS Group reaffirmed a “buy” rating on shares of Universal Health Services in a research report on Friday, May 29th. Five analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $209.07.

Trending Headlines about Universal Health Services

Here are the key news stories impacting Universal Health Services this week:

• Positive Sentiment: UHS reported second-quarter adjusted earnings of $5.98 per share, ahead of the approximately $5.94 consensus estimate, while revenue rose 8.3% year over year to $4.64 billion, exceeding expectations of $4.58 billion. Growth in both acute-care and behavioral-health operations supported the results. UHS Beats Q2 Earnings and Revenue Estimates Despite Cost Pressures
• Positive Sentiment: Management forecast 2026 adjusted EBITDA less noncontrolling interests of $2.61 billion to $2.72 billion and said it expects to remain “highly active” with share repurchases. Buybacks could provide support for per-share earnings and the stock valuation. UHS 2026 EBITDA Forecast and Buybacks
• Positive Sentiment: UHS views its Talkspace investment as an accelerator for outpatient growth, potentially expanding its behavioral-health access and digitally enabled care offerings. Why UHS Sees Talkspace as an Accelerant for Outpatient Growth
• Neutral Sentiment: Cantor Fitzgerald reaffirmed its “neutral” rating but set a $194 price target, while Barclays maintained “equal weight” and reduced its target to $168. The mixed analyst view suggests upside potential but continued caution.
• Negative Sentiment: UHS reduced its 2026 EPS guidance to $22.28-$23.65, below the roughly $23.44 analyst consensus midpoint, citing uncertainty surrounding Medicaid supplemental-payment programs. Higher labor and operating costs also remain a pressure on margins, tempering the positive earnings surprise. UHS Cuts 2026 Forecast on Medicaid Reimbursement Uncertainty

Institutional Investors Weigh In On Universal Health Services

Large investors have recently added to or reduced their stakes in the stock. CYBER HORNET ETFs LLC bought a new stake in shares of Universal Health Services during the second quarter valued at approximately $29,000. MUFG Securities EMEA plc acquired a new stake in shares of Universal Health Services in the 2nd quarter worth approximately $31,000. Brown Brothers Harriman & Co. lifted its position in Universal Health Services by 94.0% in the third quarter. Brown Brothers Harriman & Co. now owns 163 shares of the health services provider’s stock worth $33,000 after purchasing an additional 79 shares during the period. Federated Hermes Inc. acquired a new position in shares of Universal Health Services during the 4th quarter valued at $51,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of Universal Health Services in the 3rd quarter worth $60,000. 86.05% of the stock is owned by institutional investors and hedge funds.

Universal Health Services Company Profile

Universal Health Services, Inc (NYSE: UHS) is one of the largest diversified health care management companies in the United States, offering a broad spectrum of services through its acute care hospital and behavioral health segments. The company operates general acute care hospitals, surgical hospitals and ambulatory centers, as well as inpatient and outpatient behavioral health facilities. Its network provides emergency and specialized medicine, diagnostic imaging, laboratory services, advanced surgical care and rehabilitation, complemented by a comprehensive array of behavioral services including psychiatric treatment, addiction programs and developmental disabilities care.

In the acute care segment, UHS’s facilities deliver services ranging from emergency department treatment and intensive care to maternity care and outpatient surgery.